Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.108776
Revised: June 4, 2025
Accepted: July 18, 2025
Published online: October 19, 2025
Processing time: 156 Days and 18.2 Hours
Folate metabolism gene polymorphisms may play an important role in the pa
To investigate the association of folate metabolism gene polymorphisms with ASD susceptibility and symptom severity among Chinese children.
Whole-exome sequencing (WES) was conducted to systematically screen for coding region variants of key genes in the folate metabolism pathway among children with ASD, focusing on identifying polymorphisms with high mutation frequencies and potential pathogenic effects. A case-control study was then conducted to explore the association of candidate folate metabolism gene polymorphisms with the susceptibility and severity of ASD.
WES was performed on 70 children with ASD, and the case-control study included 170 children with ASD and 170 healthy controls. WES revealed that 84.3% (59/70) of children with ASD carried potentially pathogenic variants enriched in folate metabolism pathways. MTHFR C677T and MTRR A66G were significantly associated with an increased risk of ASD in both codominant and dominant models (P < 0.05). The dominant model of MTRR A66G was also significantly associated with higher scores in the domains of social relations, body and object use, social and adaptive skills, total scores on the Autism Behavior Checklist, as well as emotional reactivity, nonverbal communication, and activity level on the Childhood Autism Rating Scale (P < 0.05).
Most children with ASD carry deleterious variants in folate metabolism-related pathways. MTHFR C677T and MTRR A66G mutations are significantly associated with ASD.
Core Tip: This study screened high-frequency and potentially deleterious polymorphisms in folate metabolism-related genes among children with autism spectrum disorder (ASD) using whole-exome sequencing and explored their associations with ASD through a case-control study. The study found that specific folate metabolism gene polymorphisms were significantly associated with both ASD susceptibility and symptom severity. These findings highlight the critical role of the folate metabolism pathway in the pathogenesis of ASD and provide potential molecular targets for early risk assessment and personalized nutritional intervention strategies.